Skip to main content
Top
Published in: Canadian Journal of Anesthesia/Journal canadien d'anesthésie 11/2009

01-11-2009 | Perioperative Cardiovascular Rounds

Hemodynamic instability in septic shock

Authors: Véronique Lapointe, MD, Drago Jocov, MD, André Denault, MD

Published in: Canadian Journal of Anesthesia/Journal canadien d'anesthésie | Issue 11/2009

Login to get access

Excerpt

Septic shock is a common cause of hemodynamic instability. To optimize management, causative mechanisms need to be determined early in the process. Early diagnosis and intervention remain very important aspects in establishing a favourable outcome. Fortunately, early diagnosis can be facilitated with good clinical acumen and aided with bedside echocardiography, as illustrated in the following case. The Research Ethics Committee of the Montreal Heart Institute granted approval for the use of the related echocardiographic images for research and educational purposes. …
Appendix
Available only for authorised users
Literature
2.
go back to reference Vieillard-Baron A, Caille V, Charron C, Belliard G, Page B, Jardin F. Actual incidence of global left ventricular hypokinesia in adult septic shock. Crit Care Med 2008; 36: 1701–6.CrossRefPubMed Vieillard-Baron A, Caille V, Charron C, Belliard G, Page B, Jardin F. Actual incidence of global left ventricular hypokinesia in adult septic shock. Crit Care Med 2008; 36: 1701–6.CrossRefPubMed
3.
go back to reference Mitsuo T, Shimazaki S, Matsuda H. Right ventricular dysfunction in septic patients. Crit Care Med 1992; 20: 630–4.CrossRefPubMed Mitsuo T, Shimazaki S, Matsuda H. Right ventricular dysfunction in septic patients. Crit Care Med 1992; 20: 630–4.CrossRefPubMed
4.
go back to reference Regueira T, Bruhn A, Hasbun P, et al. Intra-abdominal hypertension: incidence and association with organ dysfunction during early septic shock. J Crit Care 2008; 23: 461–7.CrossRefPubMed Regueira T, Bruhn A, Hasbun P, et al. Intra-abdominal hypertension: incidence and association with organ dysfunction during early septic shock. J Crit Care 2008; 23: 461–7.CrossRefPubMed
5.
go back to reference Kumar A, Roberts D, Wood KE, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006; 34: 1589–96.CrossRefPubMed Kumar A, Roberts D, Wood KE, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006; 34: 1589–96.CrossRefPubMed
6.
go back to reference Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001; 345: 1368–77.CrossRefPubMed Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001; 345: 1368–77.CrossRefPubMed
7.
go back to reference Dellinger RP, Levy MM, Carlet JM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008; 36: 296–327.CrossRefPubMed Dellinger RP, Levy MM, Carlet JM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008; 36: 296–327.CrossRefPubMed
8.
go back to reference Johnson BA, Weil MH. Redefining ischemia due to circulatory failure as dual defects of oxygen deficits and of carbon dioxide excesses. Crit Care Med 1991; 19: 1432–8.PubMedCrossRef Johnson BA, Weil MH. Redefining ischemia due to circulatory failure as dual defects of oxygen deficits and of carbon dioxide excesses. Crit Care Med 1991; 19: 1432–8.PubMedCrossRef
9.
go back to reference Bernard GR, Vincent JL, Laterre PF, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001; 344: 699–709.CrossRefPubMed Bernard GR, Vincent JL, Laterre PF, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001; 344: 699–709.CrossRefPubMed
10.
go back to reference Darenberg J, Ihendyane N, Sjolin J, et al. Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: a European randomized, double-blind, placebo-controlled trial. Clin Infect Dis 2003; 37: 333–40.CrossRefPubMed Darenberg J, Ihendyane N, Sjolin J, et al. Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: a European randomized, double-blind, placebo-controlled trial. Clin Infect Dis 2003; 37: 333–40.CrossRefPubMed
Metadata
Title
Hemodynamic instability in septic shock
Authors
Véronique Lapointe, MD
Drago Jocov, MD
André Denault, MD
Publication date
01-11-2009
Publisher
Springer-Verlag
Published in
Canadian Journal of Anesthesia/Journal canadien d'anesthésie / Issue 11/2009
Print ISSN: 0832-610X
Electronic ISSN: 1496-8975
DOI
https://doi.org/10.1007/s12630-009-9168-9

Other articles of this Issue 11/2009

Canadian Journal of Anesthesia/Journal canadien d'anesthésie 11/2009 Go to the issue